O1-3-1Safety and Effectiveness of Pembrolizumab Monotherapy in NSCLC: Interim Analysis of Japan Postmarketing Surveillance
Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdy374.002
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV